MYOKARDIA INC's ticker is MYOK and the CUSIP is 62857M105. A total of 39 filers reported holding MYOKARDIA INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $55,497,000 | -15.8% | 407,075 | -40.3% | 0.02% | -21.1% |
| Q2 2020 | $65,877,000 | +92.6% | 681,813 | -6.6% | 0.02% | +58.3% |
| Q1 2020 | $34,207,000 | -35.7% | 729,672 | 0.0% | 0.01% | -20.0% |
| Q4 2019 | $53,182,000 | +39.8% | 729,672 | 0.0% | 0.02% | +25.0% |
| Q3 2019 | $38,052,000 | +86.7% | 729,672 | +79.5% | 0.01% | +100.0% |
| Q2 2019 | $20,380,000 | +1.7% | 406,465 | +5.5% | 0.01% | 0.0% |
| Q1 2019 | $20,030,000 | +53.0% | 385,266 | +43.8% | 0.01% | +20.0% |
| Q4 2018 | $13,088,000 | +37.0% | 267,862 | +82.8% | 0.01% | +66.7% |
| Q3 2018 | $9,553,000 | +999.3% | 146,520 | +118.2% | 0.00% | – |
| Q4 2016 | $869,000 | +457.1% | 67,142 | +571.4% | 0.00% | – |
| Q3 2016 | $156,000 | +254.5% | 10,000 | +145.1% | 0.00% | – |
| Q1 2016 | $44,000 | -55.1% | 4,080 | -39.1% | 0.00% | – |
| Q4 2015 | $98,000 | – | 6,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 399,360 | $54,445,000 | 40.54% |
| Copernicus Capital Management, LLC | 42,186 | $5,751,000 | 5.48% |
| Casdin Capital, LLC | 870,000 | $118,607,000 | 5.31% |
| Foresite Capital Management IV, LLC | 126,492 | $17,245,000 | 3.89% |
| Avoro Capital Advisors LLC | 1,885,000 | $256,982,000 | 3.65% |
| RTW INVESTMENTS, LP | 936,931 | $127,732,000 | 3.08% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 65,859 | $8,979,000 | 2.90% |
| Perceptive Advisors | 1,395,017 | $190,183,000 | 2.78% |
| Fernwood Investment Management, LLC | 38,547 | $5,255,000 | 2.48% |
| Grace Capital | 23,400 | $3,190,000 | 2.47% |